Thanks co3. Again my speculation listening to their evolving strategy of now smaller MT share issuance soon, going to perform their own therapeutic P1 first to prove up safety, have sufficient cash flow for at least next 12 months, etc, etc. is and I have posted many times would be very surprised if a therapeutic BP before mid 2018 or maybe even into early 2019 (could see a diagnostic BP my mid 2018). I speculate BP are asking too much, still do not accept the full science, do not want to publicly change their everything but macrophage strategies after investing so much, yet, etc, etc. and MG/JL/Board are signalling to BP not going to steal Manocept from NAVB/shareholders.
complex issues highlighted